RE4 IS MARKET ACCESS FOR ONCOLOGY TREATMENTS EASIER IN ENGLAND THAN FOR NON-ONCOLOGY TREATMENTS? AN ANALYSIS OF NICE SINGLE TECHNOLOGY APPRAISALS FROM 2017-2019
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2728
https://www.valueinhealthjournal.com/article/S1098-3015(19)35106-X/fulltext
Title :
RE4 IS MARKET ACCESS FOR ONCOLOGY TREATMENTS EASIER IN ENGLAND THAN FOR NON-ONCOLOGY TREATMENTS? AN ANALYSIS OF NICE SINGLE TECHNOLOGY APPRAISALS FROM 2017-2019
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)35106-X&doi=10.1016/j.jval.2019.09.2728
First page :
Section Title :
Open access? :
No
Section Order :
12402